GM Advisory Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,464
| Closed | -$248K | – | 221 |
|
|
2021
Q3 | $248K | Buy |
2,464
+550
| +29% | +$55.4K | 0.03% | 174 |
|
|
2021
Q2 | $271K | Buy |
+1,914
| New | +$271K | 0.03% | 171 |
|
|
2021
Q1 | – | Sell |
-3,669
| Closed | -$454K | – | 207 |
|
|
2020
Q4 | $454K | Buy |
3,669
+480
| +15% | +$59.4K | 0.06% | 110 |
|
|
2020
Q3 | $311K | Buy |
3,189
+146
| +5% | +$14.2K | 0.05% | 130 |
|
|
2020
Q2 | $475K | Buy |
3,043
+243
| +9% | +$37.9K | 0.09% | 104 |
|
|
2020
Q1 | $404K | Buy |
+2,800
| New | +$404K | 0.11% | 81 |
|